Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators
and regulons
. In the causal flow, a mutation
may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulon that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows regulated by Mutation FAM71B_code_potential_somatic
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|---|---|---|---|---|---|---|---|
CMF-05885 | FAM71B | down-regulates | ETV6 | activates | R-12 | 8 | 1 | Drugs (2) |
CMF-05886 | FAM71B | down-regulates | SRF | activates | R-1133 | 18 | 1 | Drugs (4) Regulator Drugs (0)Regulon Drugs (4)ALEPLASININ, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, VESENCUMAB |
CMF-05887 | FAM71B | down-regulates | BCL6 | activates | R-632 | 23 | 1 | Drugs (8) Regulator Drugs (0)Regulon Drugs (8)DICHLORPHENAMIDE, ALEPLASININ, SULTHIAME, ACETAZOLAMIDE, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, ACETAZOLAMIDE SODIUM, VESENCUMAB |
CMF-05888 | FAM71B | down-regulates | JUN | activates | R-215 | 25 | 1 | Drugs (7) Regulator Drugs (0)Regulon Drugs (7)SULTHIAME, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, BHQ-880 |
CMF-05889 | FAM71B | down-regulates | TFAP2C | activates | R-1346 | 15 | 1 | Drugs (4) Regulator Drugs (0)Regulon Drugs (4)ALEPLASININ, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, VESENCUMAB |
CMF-05890 | FAM71B | down-regulates | HMGA2 | activates | R-3603 | 2 | 1 | Drugs (3) |